MedPath

Preoperative Microcirculation and Postoperative Outcome After Major Vascular Surgery

Not Applicable
Withdrawn
Conditions
Surgery--Complications
Interventions
Other: Cytocam-IDF imaging device
Registration Number
NCT04679077
Lead Sponsor
Universitair Ziekenhuis Brussel
Brief Summary

The aim of the study is to determine whether there is a correlation between the microcirculation measured preoperatively in patients undergoing major vascular surgery and the postoperative mortality during hospitalization period. The microcirculation will be measured sublingually with the Cytocam-IDF imaging technique.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age ≥ 18 years

    • Males and females
    • ASA III classification
    • Written informed consent obtained by the patient
    • Elective hospital admission for major vascular surgery, both open and endovascular
Exclusion Criteria
  • Emergency surgery

    • Minor vascular procedures (e.g. varicose vein stripping; thromboembolectomy; vascular access formation)
    • Pregnancy
    • Refusal or inability to provide written informed consent (language barrier, mental retardation)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Cytocam-IDF ImagingCytocam-IDF imaging deviceAll patients will undergo the same interventional test.
Primary Outcome Measures
NameTimeMethod
Postoperative high-sensitive troponin T (hsTnT)30 days

Indicator of acute coronary syndrome

Secondary Outcome Measures
NameTimeMethod
Cardiovascular adverse events and serious adverse events30 days

Incidence of cardiovascular complications

Correlation between preoperative microcirculation and postoperative outcome during the hospitalization period.30

In addition, demographic parameters (age, weight, height) and comorbidities will be taken into account.

Cause of death30 days

Causes of death

Non-cardiovascular adverse events and serious adverse events30 days

Incidence of non-cardiovascular complications

Trial Locations

Locations (1)

UZ Brussel

🇧🇪

Jette, Brussel, Belgium

© Copyright 2025. All Rights Reserved by MedPath